hnRNP L regulates differences in expression of mouse integrin α2β1

Blood

Volumn 107, Issue 11, 2006, Pages 4391-4398

  Cheli, Yann ^a   Kunicki, Thomas J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENOUS RIBOSOMAL NUCLEOPROTEIN L; MESSENGER RNA; NUCLEOPROTEIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTRON; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RNA SPLICING; SEQUENCE ANALYSIS; THROMBOCYTE FUNCTION;

EID: 33646777183     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-12-4822     Document Type: Article

References (38)

1. Hui J, Stangl K, Lane WS, Bindereif A. HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats. Nat Struct Biol. 2003;10:33-37.
2. Stangl K, Cascorbi I, Laule M, et al. High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. Pharmacogenetics. 2000;10:133-140.
3. Li TT, Larrucea S, Souza S, et al. Genetic variation responsible for mouse strain differences in integrin {alpha}2 expression is associated with altered platelet responses to collagen. Blood. 2004;103:3396-402.
4. Hui J, Reither G, Bindereif A. Novel functional role of CA repeats and hnRNP L in RNA stability. RNA. 2003;9:931-936.
5. Di Paola J, Federici AB, Sacchi E, et al. Low platelet alpha 2 beta 1 levels in type I von Wille-brand disease correlate with impaired platelet function in a high shear stress system. Blood. 1999;93:3578-3582.
6. Jacquelin B, Tarantino M, KritzikM, et al. Allele-dependent transcriptional regulation of the human integrin alpha 2 gene. Blood. 2001;97:1721-1726.
7. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673-4680.
8. Geneste O, Raffalli F, Lang MA. Identification and characterization of a 44 kDa protein that binds specifically to the 3′-untranslated region of CYP2a5 mRNA: inducibility, subcellular distribution and possible role in mRNA stabilization. Biochem J. 1996;313(Pt 3):1029-1037.
9. Bindereif A, Green MR. An ordered pathway of snRNP binding during mammalian pre-mRNA splicing complex assembly. EMBO J. 1987;6:2415-2424.
10. Kim TD, Kim JS, Kim JH, et al. Rhythmic serotonin N-acetyltransferase mRNA degradation is essential for the maintenance of its circadian oscillation. Mol Cell Biol. 2005;25:3232-3246.
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
12. Pinol-Roma S, Swanson MS, Gall JG, Dreyfuss G. A novel heterogeneous nuclear RNP protein with a unique distribution on nascent transcripts. J Cell Biol. 1989;109:2575-2587.
13. Hui J, Hung LH, Heiner M, et al. Intronic CA-repeat and CA-rich elements: a new class of regulators of mammalian alternative splicing. EMBO J. 2005;24:1988-1998.
14. Hahm B, Kim YK, Kim JH, Kim TY, Jang SK. Heterogeneous nuclear ribonucleoprotein L interacts with the 3′ border of the internal ribosomal entry site of hepatitis C virus. J Virol. 1998;72:8782-8788.
15. Shih SC, Claffey KP. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J Biol Chem. 1999;274:1359-1365.
16. Liu X, Mertz JE. HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression. Genes Dev. 1995;9:1766-1780.
17. Stangl K, Cascorbi I, Laule M, et al. High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. Pharmacogenetics. 2000;10:133-140.
18. Pravica V, Asderakis A, Perrey C, et al. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet. 1999;26:1-3.
19. Gebhardt F, Zanker KS, Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem. 1999;274:13176-13180.
20. Han HJ, Nakamura Y. Dinucleotide repeat polymorphism in the first intron of the CSR gene. J Hum Genet. 1998;43:212-213.
21. Mateu E, Calafell F, Bonne-Tamir B, et al. Allele frequencies in a worldwide survey of a CA repeat in the first intron of the CFTR gene. Hum Hered. 1999;49:15-20.
22. Zutter MM, Painter AA, Staatz WD, Tsung YL. Regulation of 2 integrin gene expression in cells with megakaryocytic features: a common theme of three necessary elements. Blood. 1995;86:3006-3014.
23. Kunicki TJ, Nugent DJ, Staats SJ, et al. The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and is identical to the platelet glycoprotein Ia-IIa complex. J Biol Chem. 1988;263:4516-4519.
24. Farndale RW, Sixma JJ, Barnes MJ, De Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemost. 2004;2:561-573.
25. Kamiguti AS, Theakston RD, Watson SP, et al. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation. Arch Biochem Biophys. 2000;374:356-362.
26. Kehrel B, Wierwille S, Clemetson KJ, et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood. 1998;91:491-499.
27. Ichinohe T, Takayama H, Ezumi Y, et al. Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI. J Biol Chem. 1997;272:63-68.
28. Kritzik M, Savage B, Nugent DJ, et al. Nucleotide polymorphisms in the alpha 2 gene define multiple alleles which are associated with differences in platelet alpha 2 beta 1. Blood. 1998;92:2382-2388.
29. Jacquelin B, Rozenshteyn D, Kanaji S, et al. Characterization of inherited differences in transcription of the human integrin alpha 2 gene. J Biol Chem. 2001;276:23518-23524.
30. Jacquelin B, Tuleja E, Kunicki TJ, Nurden P, Nurden AT. Analysis of platelet membrane glycoprotein polymorphisms in Glanzmann thrombasthenia showed the French gypsy mutation in the alphaIIb gene to be strongly linked to the HPA-1b polymorphism in beta3. J Thromb Haemost 2003;1:573-575.
31. Samaha FF, Hibbard C, Sacks J, et al. Measurement of platelet collagen receptor density in human subjects. Arterioscler Thromb Vasc Biol. 2004;24:e181-e182.
32. Di Paola J, Jugessur A, Goldman T, et al. Platelet glycoprotein Ibalpha and integrin alphabeta polymorphisms: gene frequencies and linkage disequilibrium in a population diversity panel. J Thromb Haemost. 2005;3:1511-1521.
33. Moshfegh K, Wuillemin WA, Redondo M, et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet. 1999;353:351-354.
34. 807T gene polymorphism with myocardial infarction in younger patients. Blood. 1999;93:2449-2453.
35. Roest M, Banga JD, Grobbee DE, et al. Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in high-risk women. Circulation. 2000;102:1645-1650.
36. Matsubara Y, Murata M, Maruyama T, et al. Association between diabetic retinopathy and genetic variations in alpha-2 beta-1 integrin, a platelet receptor for collagen. Blood. 2000;95:1560-1564.
37. Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A. The alpha 2 gene coding sequences T807/A873 of the platelet collagen receptor integrin alpha2 beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood. 1999;93:3583-3586.
38. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int. 2004;11:36-42.